IVA型黏多糖贮积症患者的疼痛管理挑战
Pain management challenges in a patient with mucopolysaccharidosis IVA.
作者信息
Gurgius Marcus, Donoghue Sarah, Wallace Robyn A
机构信息
College of Health and Medicine University of Tasmania Hobart Tasmania Australia.
Tasmanian Pain Clinic St Helen's Private Hospital Consulting Suites Hobart Tasmania Australia.
出版信息
Clin Case Rep. 2024 Jul 28;12(8):e9214. doi: 10.1002/ccr3.9214. eCollection 2024 Aug.
Abstract
It is important to consider all potential pain management modalities including alternative treatment on managing complex pain presentations. Acupuncture is a treatment modality that may result in reduction of pain in patients with significant medical comorbidities due to MPS IVA.
摘要
考虑所有潜在的疼痛管理方式，包括用于处理复杂疼痛症状的替代疗法，这一点很重要。针灸是一种治疗方式，对于因IVA型粘多糖贮积症（MPS IVA）而患有严重合并症的患者，针灸可能会减轻其疼痛。
相似文献
1
Pain management challenges in a patient with mucopolysaccharidosis IVA.
Clin Case Rep. 2024 Jul 28;12(8):e9214. doi: 10.1002/ccr3.9214. eCollection 2024 Aug.
2
Recommendations for the management of MPS IVA: systematic evidence- and consensus-based guidance.
Orphanet J Rare Dis. 2019 Jun 13;14(1):137. doi: 10.1186/s13023-019-1074-9.
3
Integrated Management of an Adult Patient with Mucopolysaccharidosis type IVA: A Case Report with a Six-Year Follow-up.
Eur J Case Rep Intern Med. 2023 Dec 13;11(1):004113. doi: 10.12890/2023_004113. eCollection 2024.
4
Mucopolysaccharidosis IVA: Diagnosis, Treatment, and Management.
Int J Mol Sci. 2020 Feb 23;21(4):1517. doi: 10.3390/ijms21041517.
5
Inflammatory process and oxidative/nitrative stress: in vivo study in mucopolysaccharidosis type IV A patients under long-term enzyme replacement therapy.
Arch Biochem Biophys. 2023 Mar 15;737:109541. doi: 10.1016/j.abb.2023.109541. Epub 2023 Feb 6.
6
Review of clinical presentation and diagnosis of mucopolysaccharidosis IVA.
Mol Genet Metab. 2013 Sep-Oct;110(1-2):54-64. doi: 10.1016/j.ymgme.2013.04.002. Epub 2013 Apr 10.
7
Adjunct diagnostic value of radiological findings in mucopolysaccharidosis type IVa-related thoracic spinal abnormalities: a pilot study.
Orphanet J Rare Dis. 2022 Jul 29;17(1):296. doi: 10.1186/s13023-022-02449-9.
8
Glycosaminoglycans analysis in blood and urine of patients with mucopolysaccharidosis.
Mol Genet Metab. 2018 Sep;125(1-2):44-52. doi: 10.1016/j.ymgme.2018.04.011. Epub 2018 May 17.
9
Clinical characteristics and effects of enzyme replacement therapy with elosulfase alfa in Korean patients with mucopolysaccharidosis type IVA.
Mol Genet Metab Rep. 2022 Apr 15;31:100869. doi: 10.1016/j.ymgmr.2022.100869. eCollection 2022 Jun.
10
Addressing the need for patient-friendly medical communications: adaptation of the 2019 recommendations for the management of MPS VI and MPS IVA.
Orphanet J Rare Dis. 2022 Mar 2;17(1):91. doi: 10.1186/s13023-022-02219-7.
本文引用的文献
1
Understandings of acupuncture application and mechanisms.
Am J Transl Res. 2022 Mar 15;14(3):1469-1481. eCollection 2022.
2
Non-cardiac Manifestations in Adult Patients With Mucopolysaccharidosis.
Front Cardiovasc Med. 2022 Mar 7;9:839391. doi: 10.3389/fcvm.2022.839391. eCollection 2022.
3
Bone Biomarkers in Mucopolysaccharidoses.
Int J Mol Sci. 2021 Nov 23;22(23):12651. doi: 10.3390/ijms222312651.
4
Activity of daily living in mucopolysaccharidosis IVA patients: Evaluation of therapeutic efficacy.
Mol Genet Genomic Med. 2021 Nov;9(11):e1806. doi: 10.1002/mgg3.1806. Epub 2021 Oct 8.
5
Mucopolysaccharidosis IVA: Diagnosis, Treatment, and Management.
Int J Mol Sci. 2020 Feb 23;21(4):1517. doi: 10.3390/ijms21041517.
6
Use of complementary and alternative medicine in patients with inborn errors of metabolism: A single-center study.
JIMD Rep. 2019 Dec 18;51(1):105-112. doi: 10.1002/jmd2.12089. eCollection 2020 Jan.
7
Laser Acupuncture: A Concise Review.
Med Acupunct. 2019 Jun 1;31(3):164-168. doi: 10.1089/acu.2019.1343. Epub 2019 Jun 17.
8
Pain in Mucopolysaccharidoses: Analysis of the Problem and Possible Treatments.
Int J Mol Sci. 2018 Oct 8;19(10):3063. doi: 10.3390/ijms19103063.
9
Acupuncture for Chronic Pain: Update of an Individual Patient Data Meta-Analysis.
J Pain. 2018 May;19(5):455-474. doi: 10.1016/j.jpain.2017.11.005. Epub 2017 Dec 2.
10
The effect of galsulfase enzyme replacement therapy on the growth of patients with mucopolysaccharidosis VI (Maroteaux-Lamy syndrome).
Mol Genet Metab. 2017 Sep;122(1-2):107-112. doi: 10.1016/j.ymgme.2017.03.008. Epub 2017 Mar 31.
Zotero 插件